

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | L-phenylalanine catabolic process (GO:0006559) | 6.69113670 |
| 2 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 6.69113670 |
| 3 | L-phenylalanine metabolic process (GO:0006558) | 6.51108794 |
| 4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.51108794 |
| 5 | aromatic amino acid family catabolic process (GO:0009074) | 5.64389843 |
| 6 | glyoxylate metabolic process (GO:0046487) | 4.94785393 |
| 7 | bile acid biosynthetic process (GO:0006699) | 4.93391771 |
| 8 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.90874788 |
| 9 | tryptophan catabolic process (GO:0006569) | 4.75875176 |
| 10 | indole-containing compound catabolic process (GO:0042436) | 4.75875176 |
| 11 | indolalkylamine catabolic process (GO:0046218) | 4.75875176 |
| 12 | sulfur amino acid catabolic process (GO:0000098) | 4.74963368 |
| 13 | alpha-linolenic acid metabolic process (GO:0036109) | 4.73500631 |
| 14 | kynurenine metabolic process (GO:0070189) | 4.72585207 |
| 15 | tryptophan metabolic process (GO:0006568) | 4.50278524 |
| 16 | cysteine metabolic process (GO:0006534) | 4.45880740 |
| 17 | negative regulation of fibrinolysis (GO:0051918) | 4.45338344 |
| 18 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.42045286 |
| 19 | protein carboxylation (GO:0018214) | 4.42045286 |
| 20 | cellular ketone body metabolic process (GO:0046950) | 4.40490421 |
| 21 | regulation of protein activation cascade (GO:2000257) | 4.31608416 |
| 22 | high-density lipoprotein particle remodeling (GO:0034375) | 4.31306751 |
| 23 | complement activation, alternative pathway (GO:0006957) | 4.25897400 |
| 24 | regulation of fibrinolysis (GO:0051917) | 4.24014687 |
| 25 | coenzyme catabolic process (GO:0009109) | 4.18025449 |
| 26 | lysine catabolic process (GO:0006554) | 4.15942759 |
| 27 | lysine metabolic process (GO:0006553) | 4.15942759 |
| 28 | urea cycle (GO:0000050) | 4.15492142 |
| 29 | urea metabolic process (GO:0019627) | 4.15492142 |
| 30 | aromatic amino acid family metabolic process (GO:0009072) | 4.14891282 |
| 31 | regulation of complement activation (GO:0030449) | 4.09468212 |
| 32 | bile acid metabolic process (GO:0008206) | 4.07951175 |
| 33 | serine family amino acid catabolic process (GO:0009071) | 3.93537575 |
| 34 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.92966912 |
| 35 | nitrogen cycle metabolic process (GO:0071941) | 3.90604020 |
| 36 | reverse cholesterol transport (GO:0043691) | 3.87999843 |
| 37 | alpha-amino acid catabolic process (GO:1901606) | 3.86911640 |
| 38 | tyrosine metabolic process (GO:0006570) | 3.86323439 |
| 39 | cellular modified amino acid catabolic process (GO:0042219) | 3.81667408 |
| 40 | homocysteine metabolic process (GO:0050667) | 3.79885228 |
| 41 | ketone body metabolic process (GO:1902224) | 3.79180400 |
| 42 | regulation of cholesterol esterification (GO:0010872) | 3.76353502 |
| 43 | acylglycerol homeostasis (GO:0055090) | 3.75903189 |
| 44 | triglyceride homeostasis (GO:0070328) | 3.75903189 |
| 45 | cellular amino acid catabolic process (GO:0009063) | 3.72163409 |
| 46 | plasma lipoprotein particle remodeling (GO:0034369) | 3.71082719 |
| 47 | protein-lipid complex remodeling (GO:0034368) | 3.71082719 |
| 48 | macromolecular complex remodeling (GO:0034367) | 3.71082719 |
| 49 | glutamate metabolic process (GO:0006536) | 3.67676517 |
| 50 | regulation of triglyceride catabolic process (GO:0010896) | 3.66133434 |
| 51 | short-chain fatty acid metabolic process (GO:0046459) | 3.64227916 |
| 52 | aldehyde catabolic process (GO:0046185) | 3.58564521 |
| 53 | indolalkylamine metabolic process (GO:0006586) | 3.57076988 |
| 54 | amino-acid betaine metabolic process (GO:0006577) | 3.56972420 |
| 55 | imidazole-containing compound metabolic process (GO:0052803) | 3.47090185 |
| 56 | plasma lipoprotein particle clearance (GO:0034381) | 3.45258957 |
| 57 | cofactor catabolic process (GO:0051187) | 3.44510607 |
| 58 | ethanol oxidation (GO:0006069) | 3.43416271 |
| 59 | acetyl-CoA metabolic process (GO:0006084) | 3.37548135 |
| 60 | arginine metabolic process (GO:0006525) | 3.37547241 |
| 61 | negative regulation of sterol transport (GO:0032372) | 3.36499762 |
| 62 | negative regulation of cholesterol transport (GO:0032375) | 3.36499762 |
| 63 | 2-oxoglutarate metabolic process (GO:0006103) | 3.36428571 |
| 64 | organic acid catabolic process (GO:0016054) | 3.35288931 |
| 65 | carboxylic acid catabolic process (GO:0046395) | 3.35288931 |
| 66 | amine catabolic process (GO:0009310) | 3.32164677 |
| 67 | cellular biogenic amine catabolic process (GO:0042402) | 3.32164677 |
| 68 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 3.30324626 |
| 69 | cholesterol efflux (GO:0033344) | 3.30248398 |
| 70 | bile acid and bile salt transport (GO:0015721) | 3.29286174 |
| 71 | benzene-containing compound metabolic process (GO:0042537) | 3.29055835 |
| 72 | phospholipid efflux (GO:0033700) | 3.28095350 |
| 73 | monocarboxylic acid catabolic process (GO:0072329) | 3.27768819 |
| 74 | fatty acid beta-oxidation (GO:0006635) | 3.27335490 |
| 75 | epoxygenase P450 pathway (GO:0019373) | 3.25800443 |
| 76 | sequestering of extracellular ligand from receptor (GO:0035581) | 3.24734714 |
| 77 | aspartate family amino acid catabolic process (GO:0009068) | 3.24138349 |
| 78 | fatty acid oxidation (GO:0019395) | 3.22364248 |
| 79 | fatty acid catabolic process (GO:0009062) | 3.20797556 |
| 80 | cellular glucuronidation (GO:0052695) | 3.19281717 |
| 81 | serine family amino acid metabolic process (GO:0009069) | 3.19251063 |
| 82 | low-density lipoprotein particle remodeling (GO:0034374) | 3.19190403 |
| 83 | lipid oxidation (GO:0034440) | 3.17409619 |
| 84 | neuronal action potential propagation (GO:0019227) | 3.11911506 |
| 85 | cytolysis (GO:0019835) | 3.10738139 |
| 86 | regulation of plasminogen activation (GO:0010755) | 3.09553757 |
| 87 | fibrinolysis (GO:0042730) | 3.08974734 |
| 88 | drug catabolic process (GO:0042737) | 3.07857970 |
| 89 | presynaptic membrane assembly (GO:0097105) | 3.07003664 |
| 90 | complement activation, classical pathway (GO:0006958) | 3.05469882 |
| 91 | glycine metabolic process (GO:0006544) | 3.04562536 |
| 92 | very long-chain fatty acid metabolic process (GO:0000038) | 3.02541505 |
| 93 | complement activation (GO:0006956) | 3.02518566 |
| 94 | uronic acid metabolic process (GO:0006063) | 3.00696255 |
| 95 | glucuronate metabolic process (GO:0019585) | 3.00696255 |
| 96 | drug transmembrane transport (GO:0006855) | 3.00237477 |
| 97 | negative regulation of lipase activity (GO:0060192) | 2.97761296 |
| 98 | opsonization (GO:0008228) | 2.96729054 |
| 99 | serine family amino acid biosynthetic process (GO:0009070) | 2.96330588 |
| 100 | regulation of cholesterol homeostasis (GO:2000188) | 2.95877358 |
| 101 | regulation of axon extension involved in axon guidance (GO:0048841) | 2.95317444 |
| 102 | pyrimidine nucleobase catabolic process (GO:0006208) | 2.94415015 |
| 103 | valine metabolic process (GO:0006573) | 2.92785669 |
| 104 | negative regulation of protein localization to cell surface (GO:2000009) | 2.91881271 |
| 105 | plasma lipoprotein particle assembly (GO:0034377) | 2.91246649 |
| 106 | dicarboxylic acid biosynthetic process (GO:0043650) | 2.90781477 |
| 107 | presynaptic membrane organization (GO:0097090) | 2.88934178 |
| 108 | postsynaptic membrane organization (GO:0001941) | 2.88705337 |
| 109 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.88062739 |
| 110 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 2.82815733 |
| 111 | positive regulation of phosphoprotein phosphatase activity (GO:0032516) | 2.82347297 |
| 112 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.81762505 |
| 113 | axonal fasciculation (GO:0007413) | 2.81028819 |
| 114 | regulation of axon guidance (GO:1902667) | 2.75803418 |
| 115 | negative regulation of axon extension involved in axon guidance (GO:0048843) | 2.72325628 |
| 116 | protein heterotrimerization (GO:0070208) | 2.71274698 |
| 117 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan (GO:0019800) | 2.70567141 |
| 118 | response to gravity (GO:0009629) | 2.69036259 |
| 119 | auditory behavior (GO:0031223) | 2.66105094 |
| 120 | neuron cell-cell adhesion (GO:0007158) | 2.65925722 |
| 121 | response to pheromone (GO:0019236) | 2.64554721 |
| 122 | C4-dicarboxylate transport (GO:0015740) | 2.63389894 |
| 123 | pericardium development (GO:0060039) | 2.57984896 |
| 124 | collagen fibril organization (GO:0030199) | 2.57079911 |
| 125 | gamma-aminobutyric acid transport (GO:0015812) | 2.56564252 |
| 126 | neuron recognition (GO:0008038) | 2.49690117 |
| 127 | smooth muscle tissue development (GO:0048745) | 2.49477377 |
| 128 | lymphangiogenesis (GO:0001946) | 2.49167918 |
| 129 | vocalization behavior (GO:0071625) | 2.48223331 |
| 130 | vascular smooth muscle contraction (GO:0014829) | 2.47388367 |
| 131 | negative regulation of axon guidance (GO:1902668) | 2.46347919 |
| 132 | nonmotile primary cilium assembly (GO:0035058) | 2.46069145 |
| 133 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 2.39066944 |
| 134 | signal peptide processing (GO:0006465) | 2.38532528 |
| 135 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 2.38138060 |
| 136 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339) | 2.36603784 |
| 137 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 2.35657894 |
| 138 | detection of mechanical stimulus involved in sensory perception of sound (GO:0050910) | 2.35269701 |
| 139 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 2.33703661 |
| 140 | macroautophagy (GO:0016236) | 2.33663269 |
| 141 | regulation of cell communication by electrical coupling (GO:0010649) | 2.33193988 |
| 142 | glycosphingolipid biosynthetic process (GO:0006688) | 2.32808671 |
| 143 | startle response (GO:0001964) | 2.30242739 |
| 144 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 2.28283223 |
| 145 | negative regulation of complement activation (GO:0045916) | 2.27602963 |
| 146 | dermatan sulfate biosynthetic process (GO:0030208) | 2.26249871 |
| 147 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 2.25419935 |
| 148 | cyclic nucleotide catabolic process (GO:0009214) | 2.24769038 |
| 149 | negative regulation of nitric-oxide synthase activity (GO:0051001) | 2.24210753 |
| 150 | nucleobase catabolic process (GO:0046113) | 2.23330168 |
| 151 | regulation of action potential (GO:0098900) | 2.21704099 |
| 152 | tonic smooth muscle contraction (GO:0014820) | 2.21403434 |
| 153 | synaptic transmission, glutamatergic (GO:0035249) | 2.20931068 |
| 154 | cAMP catabolic process (GO:0006198) | 2.20926835 |
| 155 | detection of mechanical stimulus involved in sensory perception (GO:0050974) | 2.19518077 |
| 156 | regulation of cilium movement (GO:0003352) | 2.19001018 |
| 157 | membrane depolarization during action potential (GO:0086010) | 2.18050921 |
| 158 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 2.15724970 |
| 159 | positive regulation of synapse assembly (GO:0051965) | 2.14565758 |
| 160 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 2.14128744 |
| 161 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.14107691 |
| 162 | glutamate secretion (GO:0014047) | 2.13813634 |
| 163 | establishment of protein localization to Golgi (GO:0072600) | 2.12760983 |
| 164 | righting reflex (GO:0060013) | 2.12066418 |
| 165 | inner ear receptor stereocilium organization (GO:0060122) | 2.11113110 |
| 166 | mesenchymal-epithelial cell signaling (GO:0060638) | 2.10745902 |
| 167 | appendage development (GO:0048736) | 2.10261244 |
| 168 | limb development (GO:0060173) | 2.10261244 |
| 169 | dendritic spine morphogenesis (GO:0060997) | 2.09455483 |
| 170 | thyroid hormone metabolic process (GO:0042403) | 2.09083736 |
| 171 | regulation of protein glycosylation (GO:0060049) | 2.08794980 |
| 172 | positive regulation of inositol phosphate biosynthetic process (GO:0060732) | 2.07734107 |
| 173 | positive regulation of axon extension (GO:0045773) | 2.07362305 |
| 174 | chondrocyte proliferation (GO:0035988) | 2.05882553 |
| 175 | negative chemotaxis (GO:0050919) | 2.05799968 |
| 176 | protein localization to synapse (GO:0035418) | 2.05347082 |
| 177 | synapse assembly (GO:0007416) | 2.05181840 |
| 178 | positive regulation of meiosis (GO:0045836) | 2.04967711 |
| 179 | cilium morphogenesis (GO:0060271) | 2.04812351 |
| 180 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 2.04489134 |
| 181 | parturition (GO:0007567) | 2.03945714 |
| 182 | neurotransmitter-gated ion channel clustering (GO:0072578) | 2.03934102 |
| 183 | membrane assembly (GO:0071709) | 2.03564855 |
| 184 | retinal cone cell development (GO:0046549) | 2.03373504 |
| 185 | regulation of synapse assembly (GO:0051963) | 2.02836302 |
| 186 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 2.01940506 |
| 187 | detection of calcium ion (GO:0005513) | 1.99481342 |
| 188 | regulation of integrin-mediated signaling pathway (GO:2001044) | 1.98638467 |
| 189 | homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156) | 1.98346454 |
| 190 | axon extension (GO:0048675) | 1.98282509 |
| 191 | neuron-neuron synaptic transmission (GO:0007270) | 1.98211534 |
| 192 | negative regulation of protein activation cascade (GO:2000258) | 1.97892226 |
| 193 | smooth muscle contraction (GO:0006939) | 1.97225233 |
| 194 | reflex (GO:0060004) | 1.96897169 |
| 195 | central nervous system neuron axonogenesis (GO:0021955) | 1.96674993 |
| 196 | retinal ganglion cell axon guidance (GO:0031290) | 1.96655894 |
| 197 | regulation of respiratory system process (GO:0044065) | 1.95933775 |
| 198 | transmission of nerve impulse (GO:0019226) | 1.95837981 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 9.02591612 |
| 2 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 6.46320378 |
| 3 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 5.38371419 |
| 4 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 5.17709059 |
| 5 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 4.79061389 |
| 6 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 4.49544072 |
| 7 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 3.95132974 |
| 8 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 3.86652891 |
| 9 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.98122659 |
| 10 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.79872856 |
| 11 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.75095358 |
| 12 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 2.55705567 |
| 13 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.41080426 |
| 14 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.20957778 |
| 15 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.17989810 |
| 16 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.15509086 |
| 17 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.10790746 |
| 18 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.95581904 |
| 19 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.93568754 |
| 20 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.91938638 |
| 21 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.91030407 |
| 22 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.90577207 |
| 23 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.87246167 |
| 24 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.83835765 |
| 25 | P300_19829295_ChIP-Seq_ESCs_Human | 1.80209117 |
| 26 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.76478684 |
| 27 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.76388860 |
| 28 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.75117326 |
| 29 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.74741481 |
| 30 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.69838104 |
| 31 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.65742345 |
| 32 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.64366551 |
| 33 | VDR_22108803_ChIP-Seq_LS180_Human | 1.61694395 |
| 34 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.60859298 |
| 35 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.56761117 |
| 36 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.54797581 |
| 37 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.54020474 |
| 38 | CJUN_26792858_Chip-Seq_BT549_Human | 1.53952985 |
| 39 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.52760219 |
| 40 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.51911990 |
| 41 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.50646341 |
| 42 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.50434095 |
| 43 | STAT3_23295773_ChIP-Seq_U87_Human | 1.50281737 |
| 44 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.47134987 |
| 45 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.45981225 |
| 46 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.45203229 |
| 47 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.45196653 |
| 48 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.44674717 |
| 49 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.43473950 |
| 50 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.42730209 |
| 51 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.42144802 |
| 52 | FUS_26573619_Chip-Seq_HEK293_Human | 1.41947449 |
| 53 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.40706508 |
| 54 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.38179960 |
| 55 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.35185975 |
| 56 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.33977284 |
| 57 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.33435338 |
| 58 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.33350312 |
| 59 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.32369603 |
| 60 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.31975495 |
| 61 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.31431306 |
| 62 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.31112134 |
| 63 | TP53_16413492_ChIP-PET_HCT116_Human | 1.29975948 |
| 64 | AR_25329375_ChIP-Seq_VCAP_Human | 1.29813044 |
| 65 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.29381406 |
| 66 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.28543678 |
| 67 | TCF4_23295773_ChIP-Seq_U87_Human | 1.28087324 |
| 68 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.26981741 |
| 69 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.25211535 |
| 70 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.24242460 |
| 71 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.23347060 |
| 72 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.20949089 |
| 73 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.20560552 |
| 74 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.19450251 |
| 75 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.18432987 |
| 76 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.18374572 |
| 77 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.18004438 |
| 78 | EWS_26573619_Chip-Seq_HEK293_Human | 1.17863298 |
| 79 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.17385219 |
| 80 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.17169714 |
| 81 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.17063250 |
| 82 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.15869007 |
| 83 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.13334908 |
| 84 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.13005408 |
| 85 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.12374450 |
| 86 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.12080630 |
| 87 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.11836087 |
| 88 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.11240720 |
| 89 | KDM2B_26808549_Chip-Seq_REH_Human | 1.10499328 |
| 90 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.10310072 |
| 91 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.10235387 |
| 92 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.09427215 |
| 93 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.09297940 |
| 94 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.09086839 |
| 95 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 1.09047158 |
| 96 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.08850814 |
| 97 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.08528129 |
| 98 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.08316473 |
| 99 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.06845890 |
| 100 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.05094260 |
| 101 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.04135003 |
| 102 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.02714117 |
| 103 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.02714117 |
| 104 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.00007472 |
| 105 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.99439877 |
| 106 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 0.99023732 |
| 107 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 0.97525253 |
| 108 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 0.97525253 |
| 109 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.97367330 |
| 110 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.95626297 |
| 111 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.93108043 |
| 112 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 0.90968206 |
| 113 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 0.89482487 |
| 114 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 0.88297202 |
| 115 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 0.86223625 |
| 116 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.85344300 |
| 117 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.85114235 |
| 118 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.84942838 |
| 119 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.84784132 |
| 120 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.84427587 |
| 121 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.83576751 |
| 122 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.82387330 |
| 123 | GBX2_23144817_ChIP-Seq_PC3_Human | 0.82329461 |
| 124 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 0.80074903 |
| 125 | REST_21632747_ChIP-Seq_MESCs_Mouse | 0.74812465 |
| 126 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.74372488 |
| 127 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.73065171 |
| 128 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.72076126 |
| 129 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 0.71690460 |
| 130 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.71119642 |
| 131 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.70561788 |
| 132 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.70038664 |
| 133 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.68061292 |
| 134 | EOMES_21245162_ChIP-Seq_HESCs_Human | 0.67609775 |
| 135 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.67167139 |
| 136 | ZNF274_21170338_ChIP-Seq_K562_Hela | 0.67039211 |
| 137 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 0.66782438 |
| 138 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.66764667 |
| 139 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.65619937 |
| 140 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 0.65404865 |
| 141 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.64925254 |
| 142 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.64172588 |
| 143 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.63475272 |
| 144 | DROSHA_22980978_ChIP-Seq_HELA_Human | 0.62490782 |
| 145 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.62361555 |
| 146 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 0.61886658 |
| 147 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.61213676 |
| 148 | GATA1_22025678_ChIP-Seq_K562_Human | 0.61144965 |
| 149 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.60642446 |
| 150 | AR_20517297_ChIP-Seq_VCAP_Human | 0.60291110 |
| 151 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.58905676 |
| 152 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.58042426 |
| 153 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.57701441 |
| 154 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.57005527 |
| 155 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.56513629 |
| 156 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.55696045 |
| 157 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 0.55262903 |
| 158 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.54783757 |
| 159 | CBP_21632823_ChIP-Seq_H3396_Human | 0.54637044 |
| 160 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 0.54065129 |
| 161 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.53569702 |
| 162 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.52869796 |
| 163 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 0.52576228 |
| 164 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.52327732 |
| 165 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.52294695 |
| 166 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.52089910 |
| 167 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.51978782 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 7.12734273 |
| 2 | MP0005360_urolithiasis | 6.26230014 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 5.27286045 |
| 4 | MP0005365_abnormal_bile_salt | 5.17454404 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 4.30601873 |
| 6 | MP0003806_abnormal_nucleotide_metabolis | 3.51802697 |
| 7 | MP0005503_abnormal_tendon_morphology | 3.23479085 |
| 8 | MP0003252_abnormal_bile_duct | 3.14280616 |
| 9 | MP0010329_abnormal_lipoprotein_level | 3.11907282 |
| 10 | MP0009840_abnormal_foam_cell | 3.00586011 |
| 11 | MP0003195_calcinosis | 2.88064412 |
| 12 | MP0005332_abnormal_amino_acid | 2.80004743 |
| 13 | MP0001958_emphysema | 2.78423937 |
| 14 | MP0005275_abnormal_skin_tensile | 2.41424418 |
| 15 | MP0000569_abnormal_digit_pigmentation | 2.39019135 |
| 16 | MP0001666_abnormal_nutrient_absorption | 2.34639225 |
| 17 | MP0005083_abnormal_biliary_tract | 2.27662519 |
| 18 | MP0003950_abnormal_plasma_membrane | 2.15257677 |
| 19 | MP0003279_aneurysm | 2.12877373 |
| 20 | MP0004272_abnormal_basement_membrane | 2.12282329 |
| 21 | MP0006054_spinal_hemorrhage | 2.04542697 |
| 22 | MP0002118_abnormal_lipid_homeostasis | 1.96181550 |
| 23 | MP0003191_abnormal_cellular_cholesterol | 1.86547691 |
| 24 | MP0009046_muscle_twitch | 1.86183194 |
| 25 | MP0004885_abnormal_endolymph | 1.80206514 |
| 26 | MP0004019_abnormal_vitamin_homeostasis | 1.75989323 |
| 27 | MP0001968_abnormal_touch/_nociception | 1.70543453 |
| 28 | MP0003329_amyloid_beta_deposits | 1.68369815 |
| 29 | MP0000609_abnormal_liver_physiology | 1.67428451 |
| 30 | MP0001764_abnormal_homeostasis | 1.66078830 |
| 31 | MP0001542_abnormal_bone_strength | 1.65990185 |
| 32 | MP0003868_abnormal_feces_composition | 1.62460733 |
| 33 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.61271780 |
| 34 | MP0005319_abnormal_enzyme/_coenzyme | 1.59895339 |
| 35 | MP0000749_muscle_degeneration | 1.58822253 |
| 36 | MP0009745_abnormal_behavioral_response | 1.55532822 |
| 37 | MP0002138_abnormal_hepatobiliary_system | 1.55362130 |
| 38 | MP0003283_abnormal_digestive_organ | 1.55081723 |
| 39 | MP0000751_myopathy | 1.54469957 |
| 40 | MP0002735_abnormal_chemical_nociception | 1.48731832 |
| 41 | MP0002734_abnormal_mechanical_nocicepti | 1.46124968 |
| 42 | MP0002837_dystrophic_cardiac_calcinosis | 1.45963285 |
| 43 | MP0000604_amyloidosis | 1.44632127 |
| 44 | MP0004145_abnormal_muscle_electrophysio | 1.40440076 |
| 45 | MP0001299_abnormal_eye_distance/ | 1.40270145 |
| 46 | MP0002572_abnormal_emotion/affect_behav | 1.37332192 |
| 47 | MP0002108_abnormal_muscle_morphology | 1.34003784 |
| 48 | MP0003011_delayed_dark_adaptation | 1.32779201 |
| 49 | MP0005423_abnormal_somatic_nervous | 1.32497757 |
| 50 | MP0009643_abnormal_urine_homeostasis | 1.28885745 |
| 51 | MP0005623_abnormal_meninges_morphology | 1.28867814 |
| 52 | MP0000778_abnormal_nervous_system | 1.28783037 |
| 53 | MP0005535_abnormal_body_temperature | 1.27157512 |
| 54 | MP0002102_abnormal_ear_morphology | 1.26985056 |
| 55 | MP0001970_abnormal_pain_threshold | 1.26302098 |
| 56 | MP0002063_abnormal_learning/memory/cond | 1.25901517 |
| 57 | MP0001986_abnormal_taste_sensitivity | 1.25878678 |
| 58 | MP0004215_abnormal_myocardial_fiber | 1.25599735 |
| 59 | MP0002876_abnormal_thyroid_physiology | 1.24994732 |
| 60 | MP0003186_abnormal_redox_activity | 1.24097213 |
| 61 | MP0005084_abnormal_gallbladder_morpholo | 1.22378198 |
| 62 | MP0003045_fibrosis | 1.17955525 |
| 63 | MP0001879_abnormal_lymphatic_vessel | 1.17429662 |
| 64 | MP0001984_abnormal_olfaction | 1.17120928 |
| 65 | MP0005386_behavior/neurological_phenoty | 1.17036469 |
| 66 | MP0004924_abnormal_behavior | 1.17036469 |
| 67 | MP0001486_abnormal_startle_reflex | 1.16925845 |
| 68 | MP0005058_abnormal_lysosome_morphology | 1.16812031 |
| 69 | MP0006036_abnormal_mitochondrial_physio | 1.15035420 |
| 70 | MP0004084_abnormal_cardiac_muscle | 1.14252979 |
| 71 | MP0009697_abnormal_copulation | 1.12572443 |
| 72 | MP0000427_abnormal_hair_cycle | 1.12005061 |
| 73 | MP0004484_altered_response_of | 1.11335821 |
| 74 | MP0005636_abnormal_mineral_homeostasis | 1.11295973 |
| 75 | MP0008775_abnormal_heart_ventricle | 1.10714672 |
| 76 | MP0005508_abnormal_skeleton_morphology | 1.10310633 |
| 77 | MP0002909_abnormal_adrenal_gland | 1.09725318 |
| 78 | MP0002733_abnormal_thermal_nociception | 1.07830415 |
| 79 | MP0005187_abnormal_penis_morphology | 1.07351324 |
| 80 | MP0005171_absent_coat_pigmentation | 1.06716467 |
| 81 | MP0005620_abnormal_muscle_contractility | 1.06319761 |
| 82 | MP0002184_abnormal_innervation | 1.05072507 |
| 83 | MP0002078_abnormal_glucose_homeostasis | 1.04882469 |
| 84 | MP0005253_abnormal_eye_physiology | 1.04083508 |
| 85 | MP0000013_abnormal_adipose_tissue | 1.03809004 |
| 86 | MP0002168_other_aberrant_phenotype | 1.03363966 |
| 87 | MP0004858_abnormal_nervous_system | 1.02986257 |
| 88 | MP0005220_abnormal_exocrine_pancreas | 1.02734758 |
| 89 | MP0002557_abnormal_social/conspecific_i | 1.01311537 |
| 90 | MP0002067_abnormal_sensory_capabilities | 1.00751780 |
| 91 | MP0004130_abnormal_muscle_cell | 0.98838620 |
| 92 | MP0010368_abnormal_lymphatic_system | 0.96223448 |
| 93 | MP0002090_abnormal_vision | 0.94158317 |
| 94 | MP0006072_abnormal_retinal_apoptosis | 0.94157176 |
| 95 | MP0003787_abnormal_imprinting | 0.93825976 |
| 96 | MP0002254_reproductive_system_inflammat | 0.91861125 |
| 97 | MP0004134_abnormal_chest_morphology | 0.91451345 |
| 98 | MP0000767_abnormal_smooth_muscle | 0.90898725 |
| 99 | MP0003690_abnormal_glial_cell | 0.89500121 |
| 100 | MP0003122_maternal_imprinting | 0.89081190 |
| 101 | MP0009250_abnormal_appendicular_skeleto | 0.88646766 |
| 102 | MP0005451_abnormal_body_composition | 0.88593971 |
| 103 | MP0004043_abnormal_pH_regulation | 0.88354236 |
| 104 | MP0005376_homeostasis/metabolism_phenot | 0.88284376 |
| 105 | MP0005670_abnormal_white_adipose | 0.88188042 |
| 106 | MP0004036_abnormal_muscle_relaxation | 0.87505112 |
| 107 | MP0006276_abnormal_autonomic_nervous | 0.87271512 |
| 108 | MP0003646_muscle_fatigue | 0.84838259 |
| 109 | MP0000955_abnormal_spinal_cord | 0.84100889 |
| 110 | MP0000598_abnormal_liver_morphology | 0.83438954 |
| 111 | MP0006035_abnormal_mitochondrial_morpho | 0.82960388 |
| 112 | MP0009642_abnormal_blood_homeostasis | 0.82088605 |
| 113 | MP0003633_abnormal_nervous_system | 0.81972991 |
| 114 | MP0005551_abnormal_eye_electrophysiolog | 0.81611220 |
| 115 | MP0002896_abnormal_bone_mineralization | 0.81569362 |
| 116 | MP0009384_cardiac_valve_regurgitation | 0.80833371 |
| 117 | MP0003705_abnormal_hypodermis_morpholog | 0.80802901 |
| 118 | MP0009764_decreased_sensitivity_to | 0.80243773 |
| 119 | MP0002971_abnormal_brown_adipose | 0.77777682 |
| 120 | MP0001501_abnormal_sleep_pattern | 0.77586626 |
| 121 | MP0005448_abnormal_energy_balance | 0.77413231 |
| 122 | MP0003137_abnormal_impulse_conducting | 0.75578204 |
| 123 | MP0000534_abnormal_ureter_morphology | 0.75447905 |
| 124 | MP0005257_abnormal_intraocular_pressure | 0.75140789 |
| 125 | MP0001440_abnormal_grooming_behavior | 0.74914290 |
| 126 | MP0000639_abnormal_adrenal_gland | 0.74903242 |
| 127 | MP0002882_abnormal_neuron_morphology | 0.73785958 |
| 128 | MP0004085_abnormal_heartbeat | 0.73486992 |
| 129 | MP0001177_atelectasis | 0.73136011 |
| 130 | MP0008438_abnormal_cutaneous_collagen | 0.72054468 |
| 131 | MP0001756_abnormal_urination | 0.71607271 |
| 132 | MP0000230_abnormal_systemic_arterial | 0.71033846 |
| 133 | MP0003959_abnormal_lean_body | 0.71033465 |
| 134 | MP0004742_abnormal_vestibular_system | 0.70493533 |
| 135 | MP0005369_muscle_phenotype | 0.70352675 |
| 136 | MP0004510_myositis | 0.69309922 |
| 137 | MP0005647_abnormal_sex_gland | 0.68748353 |
| 138 | MP0003656_abnormal_erythrocyte_physiolo | 0.68036819 |
| 139 | MP0005266_abnormal_metabolism | 0.68019836 |
| 140 | MP0005595_abnormal_vascular_smooth | 0.67341725 |
| 141 | MP0003075_altered_response_to | 0.64307385 |
| 142 | MP0003953_abnormal_hormone_level | 0.63819823 |
| 143 | MP0005334_abnormal_fat_pad | 0.63705130 |
| 144 | MP0008469_abnormal_protein_level | 0.62521229 |
| 145 | MP0001944_abnormal_pancreas_morphology | 0.62011659 |
| 146 | MP0001661_extended_life_span | 0.60967613 |
| 147 | MP0002928_abnormal_bile_duct | 0.60675089 |
| 148 | MP0000538_abnormal_urinary_bladder | 0.59599918 |
| 149 | MP0010234_abnormal_vibrissa_follicle | 0.58738359 |
| 150 | MP0003638_abnormal_response/metabolism_ | 0.57699739 |
| 151 | MP0003635_abnormal_synaptic_transmissio | 0.57361437 |
| 152 | MP0009763_increased_sensitivity_to | 0.56854931 |
| 153 | MP0003880_abnormal_central_pattern | 0.56576764 |
| 154 | MP0002736_abnormal_nociception_after | 0.56344775 |
| 155 | MP0009780_abnormal_chondrocyte_physiolo | 0.55441550 |
| 156 | MP0001529_abnormal_vocalization | 0.55154217 |
| 157 | MP0002295_abnormal_pulmonary_circulatio | 0.54576317 |
| 158 | MP0010386_abnormal_urinary_bladder | 0.53998654 |
| 159 | MP0004859_abnormal_synaptic_plasticity | 0.53831487 |
| 160 | MP0001502_abnormal_circadian_rhythm | 0.53361442 |
| 161 | MP0002069_abnormal_eating/drinking_beha | 0.51937463 |
| 162 | MP0008874_decreased_physiological_sensi | 0.51322290 |
| 163 | MP0005645_abnormal_hypothalamus_physiol | 0.49892104 |
| 164 | MP0002064_seizures | 0.49498407 |
| 165 | MP0004142_abnormal_muscle_tone | 0.49321986 |
| 166 | MP0004270_analgesia | 0.48924659 |
| 167 | MP0005164_abnormal_response_to | 0.47919297 |
| 168 | MP0002272_abnormal_nervous_system | 0.46145981 |
| 169 | MP0001765_abnormal_ion_homeostasis | 0.45617907 |
| 170 | MP0003879_abnormal_hair_cell | 0.43525902 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 6.57408029 |
| 2 | Deep venous thrombosis (HP:0002625) | 5.62249813 |
| 3 | Intrahepatic cholestasis (HP:0001406) | 5.58227788 |
| 4 | Xanthomatosis (HP:0000991) | 5.18485831 |
| 5 | Hypobetalipoproteinemia (HP:0003563) | 4.89185075 |
| 6 | Prolonged partial thromboplastin time (HP:0003645) | 4.78785777 |
| 7 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 4.74221085 |
| 8 | Hyperlipoproteinemia (HP:0010980) | 4.56345704 |
| 9 | Premature rupture of membranes (HP:0001788) | 4.46763199 |
| 10 | Ketosis (HP:0001946) | 4.42971037 |
| 11 | Complement deficiency (HP:0004431) | 4.27524918 |
| 12 | Hyperammonemia (HP:0001987) | 4.04669606 |
| 13 | Hyperglycinemia (HP:0002154) | 4.01491000 |
| 14 | Follicular hyperkeratosis (HP:0007502) | 3.89581675 |
| 15 | Hypoglycemic coma (HP:0001325) | 3.81000568 |
| 16 | Hypolipoproteinemia (HP:0010981) | 3.78380202 |
| 17 | Ketoacidosis (HP:0001993) | 3.74718869 |
| 18 | Abnormality of glycine metabolism (HP:0010895) | 3.69800753 |
| 19 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.69800753 |
| 20 | Hyperglycinuria (HP:0003108) | 3.65400614 |
| 21 | Soft skin (HP:0000977) | 3.63624689 |
| 22 | Aortic dissection (HP:0002647) | 3.62653887 |
| 23 | Abnormality of the common coagulation pathway (HP:0010990) | 3.54069954 |
| 24 | Hyperventilation (HP:0002883) | 3.41386108 |
| 25 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.40911842 |
| 26 | Hypoalphalipoproteinemia (HP:0003233) | 3.39358216 |
| 27 | Abnormality of the intrinsic pathway (HP:0010989) | 3.39278238 |
| 28 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.38828227 |
| 29 | Protrusio acetabuli (HP:0003179) | 3.36210568 |
| 30 | Fat malabsorption (HP:0002630) | 3.28574338 |
| 31 | Epidermoid cyst (HP:0200040) | 3.21755875 |
| 32 | Type II lissencephaly (HP:0007260) | 3.21234795 |
| 33 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.20910073 |
| 34 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.19626226 |
| 35 | Vascular tortuosity (HP:0004948) | 3.19083037 |
| 36 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.14191126 |
| 37 | Joint hemorrhage (HP:0005261) | 3.10604835 |
| 38 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.10097021 |
| 39 | Cerebral edema (HP:0002181) | 3.06161933 |
| 40 | Keratoconus (HP:0000563) | 3.01332332 |
| 41 | Increased corneal curvature (HP:0100692) | 3.01332332 |
| 42 | Abnormality of methionine metabolism (HP:0010901) | 2.99611867 |
| 43 | Abnormality of complement system (HP:0005339) | 2.94091796 |
| 44 | Type 1 muscle fiber predominance (HP:0003803) | 2.89634503 |
| 45 | Conjugated hyperbilirubinemia (HP:0002908) | 2.88282312 |
| 46 | Abnormality of serum amino acid levels (HP:0003112) | 2.84825870 |
| 47 | Aortic aneurysm (HP:0004942) | 2.84720669 |
| 48 | Gout (HP:0001997) | 2.84208763 |
| 49 | Absent speech (HP:0001344) | 2.81346079 |
| 50 | Arterial tortuosity (HP:0005116) | 2.79733607 |
| 51 | Delayed CNS myelination (HP:0002188) | 2.79322304 |
| 52 | Focal motor seizures (HP:0011153) | 2.79115241 |
| 53 | Lethargy (HP:0001254) | 2.78450277 |
| 54 | Abnormality of midbrain morphology (HP:0002418) | 2.77662863 |
| 55 | Molar tooth sign on MRI (HP:0002419) | 2.77662863 |
| 56 | Broad metatarsal (HP:0001783) | 2.71780948 |
| 57 | Hypercholesterolemia (HP:0003124) | 2.70228697 |
| 58 | Focal seizures (HP:0007359) | 2.69497674 |
| 59 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.68588570 |
| 60 | Dicarboxylic aciduria (HP:0003215) | 2.68588570 |
| 61 | Gaze-evoked nystagmus (HP:0000640) | 2.67623890 |
| 62 | Febrile seizures (HP:0002373) | 2.66648797 |
| 63 | Metabolic acidosis (HP:0001942) | 2.66483064 |
| 64 | Abnormality of dentin (HP:0010299) | 2.65572182 |
| 65 | Pancreatic fibrosis (HP:0100732) | 2.64135872 |
| 66 | Hyperbilirubinemia (HP:0002904) | 2.61725462 |
| 67 | Skin nodule (HP:0200036) | 2.58634367 |
| 68 | Pancreatic cysts (HP:0001737) | 2.58189038 |
| 69 | Hypoglycemic seizures (HP:0002173) | 2.58125341 |
| 70 | Hemiparesis (HP:0001269) | 2.55084853 |
| 71 | Steatorrhea (HP:0002570) | 2.53762879 |
| 72 | Acute encephalopathy (HP:0006846) | 2.53006214 |
| 73 | Medial flaring of the eyebrow (HP:0010747) | 2.50725550 |
| 74 | Atonic seizures (HP:0010819) | 2.49583734 |
| 75 | Abnormality of the calf musculature (HP:0001430) | 2.49474842 |
| 76 | Bladder diverticulum (HP:0000015) | 2.47150147 |
| 77 | Delayed gross motor development (HP:0002194) | 2.46293153 |
| 78 | Gait imbalance (HP:0002141) | 2.45476517 |
| 79 | Hepatic necrosis (HP:0002605) | 2.44636383 |
| 80 | Abnormality of purine metabolism (HP:0004352) | 2.44293473 |
| 81 | Calf muscle hypertrophy (HP:0008981) | 2.44020707 |
| 82 | Atrophic scars (HP:0001075) | 2.41917901 |
| 83 | Neonatal short-limb short stature (HP:0008921) | 2.39154620 |
| 84 | Late onset (HP:0003584) | 2.37751873 |
| 85 | Cholecystitis (HP:0001082) | 2.37203570 |
| 86 | Abnormal gallbladder physiology (HP:0012438) | 2.37203570 |
| 87 | Irritability (HP:0000737) | 2.35974332 |
| 88 | True hermaphroditism (HP:0010459) | 2.34660664 |
| 89 | Sensorimotor neuropathy (HP:0007141) | 2.34295111 |
| 90 | Striae distensae (HP:0001065) | 2.32245826 |
| 91 | Generalized aminoaciduria (HP:0002909) | 2.29861905 |
| 92 | Abnormal gallbladder morphology (HP:0012437) | 2.29768891 |
| 93 | Vomiting (HP:0002013) | 2.27982544 |
| 94 | Abnormality of nucleobase metabolism (HP:0010932) | 2.26478251 |
| 95 | Amyloidosis (HP:0011034) | 2.23263403 |
| 96 | Hepatocellular carcinoma (HP:0001402) | 2.21098490 |
| 97 | Neonatal onset (HP:0003623) | 2.20432212 |
| 98 | Brushfield spots (HP:0001088) | 2.18801139 |
| 99 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.18349894 |
| 100 | Cholelithiasis (HP:0001081) | 2.17443423 |
| 101 | Congenital primary aphakia (HP:0007707) | 2.17074344 |
| 102 | Systemic lupus erythematosus (HP:0002725) | 2.16481082 |
| 103 | Genetic anticipation (HP:0003743) | 2.15598144 |
| 104 | Mitral stenosis (HP:0001718) | 2.14417513 |
| 105 | Muscle hypertrophy of the lower extremities (HP:0008968) | 2.14103755 |
| 106 | Congenital stationary night blindness (HP:0007642) | 2.12494751 |
| 107 | Inability to walk (HP:0002540) | 2.11527298 |
| 108 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.11269037 |
| 109 | Wide anterior fontanel (HP:0000260) | 2.10254785 |
| 110 | Vascular calcification (HP:0004934) | 2.10197456 |
| 111 | Ragged-red muscle fibers (HP:0003200) | 2.09624508 |
| 112 | Spontaneous abortion (HP:0005268) | 2.08636340 |
| 113 | Broad-based gait (HP:0002136) | 2.08338694 |
| 114 | Neurofibrillary tangles (HP:0002185) | 2.07763887 |
| 115 | Myoglobinuria (HP:0002913) | 2.07548131 |
| 116 | Coronal craniosynostosis (HP:0004440) | 2.06601674 |
| 117 | Infantile muscular hypotonia (HP:0008947) | 2.05476644 |
| 118 | Progressive cerebellar ataxia (HP:0002073) | 2.05380373 |
| 119 | Hepatocellular necrosis (HP:0001404) | 2.04674341 |
| 120 | Wormian bones (HP:0002645) | 2.03717034 |
| 121 | Pancreatitis (HP:0001733) | 2.03570919 |
| 122 | Ankle contracture (HP:0006466) | 2.02632376 |
| 123 | Chronic hepatic failure (HP:0100626) | 2.01800095 |
| 124 | Polyphagia (HP:0002591) | 2.01711136 |
| 125 | Glomerulonephritis (HP:0000099) | 2.00971243 |
| 126 | Opisthotonus (HP:0002179) | 2.00255009 |
| 127 | Drooling (HP:0002307) | 2.00121753 |
| 128 | Aortic regurgitation (HP:0001659) | 1.98758678 |
| 129 | Abnormality of urine glucose concentration (HP:0011016) | 1.98694066 |
| 130 | Glycosuria (HP:0003076) | 1.98694066 |
| 131 | Nephrogenic diabetes insipidus (HP:0009806) | 1.97509954 |
| 132 | Fair hair (HP:0002286) | 1.96924843 |
| 133 | Cardiovascular calcification (HP:0011915) | 1.96776002 |
| 134 | Malnutrition (HP:0004395) | 1.96625938 |
| 135 | Acute necrotizing encephalopathy (HP:0006965) | 1.96205205 |
| 136 | Action tremor (HP:0002345) | 1.95181541 |
| 137 | Overgrowth (HP:0001548) | 1.94217818 |
| 138 | Arthropathy (HP:0003040) | 1.93740743 |
| 139 | Methylmalonic aciduria (HP:0012120) | 1.93140590 |
| 140 | Abnormality of proline metabolism (HP:0010907) | 1.92994333 |
| 141 | Hydroxyprolinuria (HP:0003080) | 1.92994333 |
| 142 | Prolonged QT interval (HP:0001657) | 1.92808776 |
| 143 | Hyperextensible skin (HP:0000974) | 1.92289598 |
| 144 | Large for gestational age (HP:0001520) | 1.92190261 |
| 145 | Broad ribs (HP:0000885) | 1.90907772 |
| 146 | Abnormality of pyrimidine metabolism (HP:0004353) | 1.90847809 |
| 147 | Abnormality of the gallbladder (HP:0005264) | 1.89591830 |
| 148 | Genital tract atresia (HP:0001827) | 1.89426893 |
| 149 | Progressive inability to walk (HP:0002505) | 1.88641646 |
| 150 | Limited hip movement (HP:0008800) | 1.88220883 |
| 151 | Myocardial infarction (HP:0001658) | 1.87775584 |
| 152 | Bowel diverticulosis (HP:0005222) | 1.87745559 |
| 153 | Hemiplegia (HP:0002301) | 1.87152800 |
| 154 | Abnormality of the Achilles tendon (HP:0005109) | 1.86602830 |
| 155 | Slender build (HP:0001533) | 1.85846233 |
| 156 | Short foot (HP:0001773) | 1.85778112 |
| 157 | Increased muscle lipid content (HP:0009058) | 1.85184044 |
| 158 | Facial diplegia (HP:0001349) | 1.84111629 |
| 159 | Neuroendocrine neoplasm (HP:0100634) | 1.83526692 |
| 160 | Fetal akinesia sequence (HP:0001989) | 1.83222377 |
| 161 | Vaginal atresia (HP:0000148) | 1.83154302 |
| 162 | Abnormal cartilage morphology (HP:0002763) | 1.82754975 |
| 163 | Generalized tonic-clonic seizures (HP:0002069) | 1.81277069 |
| 164 | Craniofacial dystonia (HP:0012179) | 1.81074320 |
| 165 | Spastic diplegia (HP:0001264) | 1.80717643 |
| 166 | Metaphyseal dysplasia (HP:0100255) | 1.80408718 |
| 167 | Status epilepticus (HP:0002133) | 1.79909026 |
| 168 | Dialeptic seizures (HP:0011146) | 1.79342372 |
| 169 | Abnormality of glycolysis (HP:0004366) | 1.78877710 |
| 170 | Increased serum pyruvate (HP:0003542) | 1.78877710 |
| 171 | Alkalosis (HP:0001948) | 1.78162995 |
| 172 | Symptomatic seizures (HP:0011145) | 1.78015690 |
| 173 | Cerebral inclusion bodies (HP:0100314) | 1.77771380 |
| 174 | Lactic acidosis (HP:0003128) | 1.77309210 |
| 175 | Excessive salivation (HP:0003781) | 1.76537420 |
| 176 | Absence seizures (HP:0002121) | 1.76400100 |
| 177 | Hypoventilation (HP:0002791) | 1.76165396 |
| 178 | Nephronophthisis (HP:0000090) | 1.75774110 |
| 179 | Cystic liver disease (HP:0006706) | 1.75183905 |
| 180 | Left ventricular hypertrophy (HP:0001712) | 1.73781628 |
| 181 | Congenital sensorineural hearing impairment (HP:0008527) | 1.73025476 |
| 182 | Round ear (HP:0100830) | 1.72551227 |
| 183 | Aplasia/Hypoplasia of the lens (HP:0008063) | 1.72508030 |
| 184 | Agitation (HP:0000713) | 1.70515385 |
| 185 | Limb-girdle muscle weakness (HP:0003325) | 1.69962739 |
| 186 | Mild short stature (HP:0003502) | 1.69466904 |
| 187 | Bundle branch block (HP:0011710) | 1.68499915 |
| 188 | Cerebellar dysplasia (HP:0007033) | 1.67032053 |
| 189 | Shallow orbits (HP:0000586) | 1.66079713 |
| 190 | Thyroid-stimulating hormone excess (HP:0002925) | 1.65650956 |
| 191 | Bulbous nose (HP:0000414) | 1.65333942 |
| 192 | Chorioretinal atrophy (HP:0000533) | 1.64837578 |
| 193 | Peritonitis (HP:0002586) | 1.64636525 |
| 194 | Postaxial hand polydactyly (HP:0001162) | 1.64497207 |
| 195 | Genu recurvatum (HP:0002816) | 1.62127383 |
| 196 | Atrial fibrillation (HP:0005110) | 1.61978275 |
| 197 | Abnormality of the renal medulla (HP:0100957) | 1.61937007 |
| 198 | Hip contracture (HP:0003273) | 1.61410787 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 6.17023972 |
| 2 | ERN1 | 3.92248881 |
| 3 | CASK | 3.69868103 |
| 4 | INSRR | 3.13841166 |
| 5 | ARAF | 3.02159591 |
| 6 | FGFR4 | 2.80410623 |
| 7 | SIK1 | 2.18530699 |
| 8 | ADRBK2 | 1.99852871 |
| 9 | TRIB3 | 1.77742067 |
| 10 | MAP3K9 | 1.72349973 |
| 11 | AKT3 | 1.71429768 |
| 12 | MAP3K13 | 1.70918828 |
| 13 | ACVR1B | 1.70327848 |
| 14 | GRK1 | 1.64031036 |
| 15 | MAP2K4 | 1.60469368 |
| 16 | EPHA4 | 1.53767183 |
| 17 | PAK3 | 1.50557465 |
| 18 | TNIK | 1.46805549 |
| 19 | ERBB4 | 1.43964477 |
| 20 | GRK7 | 1.41579156 |
| 21 | BMPR1B | 1.40729405 |
| 22 | STK16 | 1.40721091 |
| 23 | NTRK1 | 1.40169603 |
| 24 | PKN2 | 1.38176182 |
| 25 | MAPK13 | 1.37364366 |
| 26 | PRKCE | 1.37350275 |
| 27 | PLK2 | 1.36984172 |
| 28 | EPHA3 | 1.35939610 |
| 29 | ADRBK1 | 1.35602761 |
| 30 | FLT3 | 1.32266410 |
| 31 | KSR2 | 1.32175026 |
| 32 | LMTK2 | 1.30348225 |
| 33 | OBSCN | 1.29289874 |
| 34 | ERBB3 | 1.25702043 |
| 35 | NTRK3 | 1.21719487 |
| 36 | FGFR2 | 1.20027035 |
| 37 | KSR1 | 1.17884919 |
| 38 | STK39 | 1.17870529 |
| 39 | PINK1 | 1.17204993 |
| 40 | CAMK2G | 1.14347682 |
| 41 | MYLK | 1.14305218 |
| 42 | MINK1 | 1.13751517 |
| 43 | MAPK15 | 1.13549293 |
| 44 | PHKG2 | 1.12468399 |
| 45 | PHKG1 | 1.12468399 |
| 46 | TRPM7 | 1.09161794 |
| 47 | PIK3CG | 1.07656346 |
| 48 | MAP4K2 | 1.06839847 |
| 49 | NEK9 | 1.03781968 |
| 50 | BRAF | 1.03470238 |
| 51 | STK38L | 1.03260453 |
| 52 | TLK1 | 1.03010227 |
| 53 | ABL2 | 1.02976570 |
| 54 | CSNK1G3 | 1.01276882 |
| 55 | KDR | 1.00799145 |
| 56 | TIE1 | 0.99962676 |
| 57 | SGK2 | 0.96912695 |
| 58 | NLK | 0.94216157 |
| 59 | MAP3K6 | 0.93117916 |
| 60 | OXSR1 | 0.90894080 |
| 61 | DAPK2 | 0.90877233 |
| 62 | DDR2 | 0.90394985 |
| 63 | FER | 0.89565854 |
| 64 | CSNK1G2 | 0.88396352 |
| 65 | PNCK | 0.88233674 |
| 66 | MAP2K1 | 0.84447635 |
| 67 | NUAK1 | 0.83848051 |
| 68 | PTK6 | 0.83588622 |
| 69 | PRKCG | 0.82908800 |
| 70 | GRK5 | 0.82013979 |
| 71 | TAOK3 | 0.81441169 |
| 72 | BCR | 0.80681825 |
| 73 | ROCK1 | 0.80400136 |
| 74 | DYRK1B | 0.79444941 |
| 75 | ZAK | 0.79150131 |
| 76 | RAF1 | 0.78673348 |
| 77 | LATS1 | 0.78626722 |
| 78 | PTK2 | 0.78582697 |
| 79 | CAMKK2 | 0.77331632 |
| 80 | SGK223 | 0.77127863 |
| 81 | SGK494 | 0.77127863 |
| 82 | MARK1 | 0.76500822 |
| 83 | PRKD3 | 0.76233728 |
| 84 | STK38 | 0.75907490 |
| 85 | RIPK1 | 0.75189306 |
| 86 | MUSK | 0.74851338 |
| 87 | CSNK1G1 | 0.74323341 |
| 88 | MAP3K12 | 0.73492074 |
| 89 | PRKCZ | 0.71418767 |
| 90 | MAP3K4 | 0.70968050 |
| 91 | MAPK11 | 0.70244279 |
| 92 | PIK3CA | 0.70235923 |
| 93 | CAMK2A | 0.69297782 |
| 94 | TYK2 | 0.68977667 |
| 95 | WNK4 | 0.68796156 |
| 96 | PDGFRA | 0.68526579 |
| 97 | RET | 0.68091908 |
| 98 | NTRK2 | 0.65314901 |
| 99 | PAK6 | 0.64665606 |
| 100 | SCYL2 | 0.62589166 |
| 101 | TBK1 | 0.62520252 |
| 102 | CDK5 | 0.62479077 |
| 103 | PDK2 | 0.62020444 |
| 104 | MAPK7 | 0.61797806 |
| 105 | MAP3K11 | 0.61647918 |
| 106 | CAMK2B | 0.61562492 |
| 107 | MAP3K7 | 0.61172958 |
| 108 | JAK2 | 0.61074575 |
| 109 | LIMK1 | 0.60992042 |
| 110 | TGFBR2 | 0.59994461 |
| 111 | CAMK2D | 0.57751211 |
| 112 | WNK3 | 0.57683818 |
| 113 | PDGFRB | 0.57542947 |
| 114 | PRKACG | 0.57310217 |
| 115 | FRK | 0.56535876 |
| 116 | MAP2K7 | 0.55489918 |
| 117 | DYRK1A | 0.55198465 |
| 118 | IRAK2 | 0.55113121 |
| 119 | MOS | 0.54652242 |
| 120 | MST1R | 0.54594078 |
| 121 | EPHB1 | 0.54411884 |
| 122 | MAPK12 | 0.54071971 |
| 123 | CSNK1A1L | 0.53362726 |
| 124 | CAMK1 | 0.52918943 |
| 125 | TAOK2 | 0.52021361 |
| 126 | MAP3K1 | 0.51153868 |
| 127 | PRKCH | 0.50054219 |
| 128 | GRK6 | 0.49810684 |
| 129 | UHMK1 | 0.49624716 |
| 130 | NEK1 | 0.49575908 |
| 131 | MET | 0.49377872 |
| 132 | PDPK1 | 0.49118953 |
| 133 | MAPKAPK3 | 0.48513725 |
| 134 | MAP2K2 | 0.47695991 |
| 135 | PTK2B | 0.47137149 |
| 136 | CAMKK1 | 0.46925829 |
| 137 | ROCK2 | 0.45693853 |
| 138 | CDK19 | 0.45520481 |
| 139 | CDK14 | 0.44827165 |
| 140 | JAK1 | 0.44454505 |
| 141 | KIT | 0.43722203 |
| 142 | PRKG1 | 0.43516252 |
| 143 | TESK1 | 0.43321528 |
| 144 | PRKAA2 | 0.43211823 |
| 145 | GSK3A | 0.43099769 |
| 146 | PKN1 | 0.42954234 |
| 147 | PRKACA | 0.42790001 |
| 148 | FGFR1 | 0.42498869 |
| 149 | EPHB2 | 0.42242065 |
| 150 | PDK4 | 0.41638016 |
| 151 | PDK3 | 0.41638016 |
| 152 | SGK3 | 0.38553530 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.99721495 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.45317055 |
| 3 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.95550609 |
| 4 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.74061180 |
| 5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.65904328 |
| 6 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.60843171 |
| 7 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.59399124 |
| 8 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.56181619 |
| 9 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.53207352 |
| 10 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.51401461 |
| 11 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.39410847 |
| 12 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.26055578 |
| 13 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.23279015 |
| 14 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.21259846 |
| 15 | Peroxisome_Homo sapiens_hsa04146 | 2.03511690 |
| 16 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.03366941 |
| 17 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.96400044 |
| 18 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.85368778 |
| 19 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.79297353 |
| 20 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.75845143 |
| 21 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.74861860 |
| 22 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.74543834 |
| 23 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.73314449 |
| 24 | Morphine addiction_Homo sapiens_hsa05032 | 1.73096169 |
| 25 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.72962735 |
| 26 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.70344281 |
| 27 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.67293680 |
| 28 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.66829163 |
| 29 | Histidine metabolism_Homo sapiens_hsa00340 | 1.64302744 |
| 30 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.63828996 |
| 31 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.60028300 |
| 32 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.58818567 |
| 33 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.58544733 |
| 34 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.57445189 |
| 35 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.55479120 |
| 36 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.52822764 |
| 37 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.51498319 |
| 38 | Circadian entrainment_Homo sapiens_hsa04713 | 1.50101243 |
| 39 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.49844310 |
| 40 | Bile secretion_Homo sapiens_hsa04976 | 1.49405477 |
| 41 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.48727711 |
| 42 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.46890228 |
| 43 | Circadian rhythm_Homo sapiens_hsa04710 | 1.41511220 |
| 44 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.38611241 |
| 45 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.34275029 |
| 46 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.34194528 |
| 47 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.34173241 |
| 48 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.32940330 |
| 49 | Protein digestion and absorption_Homo sapiens_hsa04974 | 1.31135565 |
| 50 | Renin secretion_Homo sapiens_hsa04924 | 1.28168358 |
| 51 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.27579938 |
| 52 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.26783710 |
| 53 | Carbon metabolism_Homo sapiens_hsa01200 | 1.25866266 |
| 54 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.24941915 |
| 55 | Phototransduction_Homo sapiens_hsa04744 | 1.24738004 |
| 56 | Retinol metabolism_Homo sapiens_hsa00830 | 1.24240630 |
| 57 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.23181283 |
| 58 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.21985966 |
| 59 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.21644496 |
| 60 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.17140912 |
| 61 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.15883245 |
| 62 | Salivary secretion_Homo sapiens_hsa04970 | 1.15482903 |
| 63 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.15358758 |
| 64 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.12175352 |
| 65 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.11904015 |
| 66 | Taste transduction_Homo sapiens_hsa04742 | 1.11779336 |
| 67 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.09150248 |
| 68 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.08318497 |
| 69 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.05692816 |
| 70 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.04444530 |
| 71 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.03647575 |
| 72 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.03432031 |
| 73 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.03291107 |
| 74 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.03244966 |
| 75 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.02819804 |
| 76 | Axon guidance_Homo sapiens_hsa04360 | 1.01168578 |
| 77 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.01078273 |
| 78 | Mineral absorption_Homo sapiens_hsa04978 | 1.00361208 |
| 79 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.99298939 |
| 80 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.99152940 |
| 81 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.98396098 |
| 82 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.97275050 |
| 83 | Sulfur relay system_Homo sapiens_hsa04122 | 0.96654530 |
| 84 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.93545481 |
| 85 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.92638172 |
| 86 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.92189150 |
| 87 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.91955488 |
| 88 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.91468024 |
| 89 | ABC transporters_Homo sapiens_hsa02010 | 0.91309836 |
| 90 | Focal adhesion_Homo sapiens_hsa04510 | 0.90999292 |
| 91 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.90196332 |
| 92 | Long-term depression_Homo sapiens_hsa04730 | 0.87672159 |
| 93 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.82654725 |
| 94 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.81500602 |
| 95 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.79945780 |
| 96 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.78064431 |
| 97 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.77694330 |
| 98 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.74844919 |
| 99 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.74801937 |
| 100 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.74444606 |
| 101 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.74249734 |
| 102 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.70493664 |
| 103 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.66853308 |
| 104 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.66689595 |
| 105 | Prion diseases_Homo sapiens_hsa05020 | 0.66091516 |
| 106 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.62350479 |
| 107 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.61929268 |
| 108 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.60937111 |
| 109 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.59582137 |
| 110 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.58838691 |
| 111 | Parkinsons disease_Homo sapiens_hsa05012 | 0.57091984 |
| 112 | Metabolic pathways_Homo sapiens_hsa01100 | 0.56665106 |
| 113 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.56514332 |
| 114 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.56486189 |
| 115 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.55512369 |
| 116 | Protein export_Homo sapiens_hsa03060 | 0.55190486 |
| 117 | Olfactory transduction_Homo sapiens_hsa04740 | 0.55013164 |
| 118 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.54809195 |
| 119 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.54190137 |
| 120 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.53618630 |
| 121 | Melanogenesis_Homo sapiens_hsa04916 | 0.52873089 |
| 122 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.52703829 |
| 123 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.50747985 |
| 124 | GABAergic synapse_Homo sapiens_hsa04727 | 0.49941752 |
| 125 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.49611842 |
| 126 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.48072057 |
| 127 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.45615684 |
| 128 | Galactose metabolism_Homo sapiens_hsa00052 | 0.42824461 |
| 129 | Alzheimers disease_Homo sapiens_hsa05010 | 0.42322742 |
| 130 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.41763150 |
| 131 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.41198261 |
| 132 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.39489122 |
| 133 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.30568211 |
| 134 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.29210303 |
| 135 | Lysosome_Homo sapiens_hsa04142 | 0.28818935 |
| 136 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.28359537 |
| 137 | Insulin secretion_Homo sapiens_hsa04911 | 0.23897234 |
| 138 | Lysine degradation_Homo sapiens_hsa00310 | 0.22126502 |
| 139 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.21903404 |
| 140 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.21386842 |
| 141 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.20994950 |
| 142 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.20634776 |
| 143 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.19881507 |
| 144 | Nicotine addiction_Homo sapiens_hsa05033 | 0.18941722 |
| 145 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.18240084 |
| 146 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.17441615 |
| 147 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.16505232 |
| 148 | Insulin resistance_Homo sapiens_hsa04931 | 0.16369559 |
| 149 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.12244160 |
| 150 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.11981670 |
| 151 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.10624360 |
| 152 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.10290291 |
| 153 | Huntingtons disease_Homo sapiens_hsa05016 | 0.07652540 |
| 154 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.06724829 |
| 155 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.05637738 |
| 156 | Cocaine addiction_Homo sapiens_hsa05030 | 0.05081755 |
| 157 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.04780595 |

